Harrison Seth Loring sold STOK
July 16, 2026 · Form 4 insider transaction
Harrison Seth Loring sold 19,441 shares of Stoke Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
19,441
Price
$0.00
Total value
N/A
InsiderHarrison Seth Loring
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeG: Gift
Transaction dateJuly 16, 2026
Filing dateJuly 17, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended.; This option is fully vested and exercisable. Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 13, 2024.